SOLLINI, MARTINA
 Distribuzione geografica
Continente #
AS - Asia 2.333
EU - Europa 2.177
NA - Nord America 1.518
SA - Sud America 412
AF - Africa 79
OC - Oceania 24
Totale 6.543
Nazione #
US - Stati Uniti d'America 1.425
RU - Federazione Russa 1.181
SG - Singapore 958
CN - Cina 688
IT - Italia 515
BR - Brasile 348
HK - Hong Kong 297
VN - Vietnam 151
FR - Francia 96
DE - Germania 89
GB - Regno Unito 72
NL - Olanda 66
FI - Finlandia 53
IN - India 50
CA - Canada 45
MX - Messico 41
AR - Argentina 23
MA - Marocco 23
PL - Polonia 23
AT - Austria 22
AU - Australia 22
JP - Giappone 22
ZA - Sudafrica 21
BD - Bangladesh 19
PK - Pakistan 17
TR - Turchia 17
ES - Italia 13
SA - Arabia Saudita 12
TH - Thailandia 12
LT - Lituania 11
DZ - Algeria 10
EG - Egitto 10
ID - Indonesia 10
IQ - Iraq 10
SE - Svezia 10
EC - Ecuador 9
CO - Colombia 8
PH - Filippine 8
TW - Taiwan 8
MY - Malesia 7
UZ - Uzbekistan 7
VE - Venezuela 7
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
KR - Corea 5
TN - Tunisia 5
BE - Belgio 4
BO - Bolivia 4
CL - Cile 4
IL - Israele 4
UA - Ucraina 4
BA - Bosnia-Erzegovina 3
IE - Irlanda 3
JO - Giordania 3
KE - Kenya 3
NP - Nepal 3
OM - Oman 3
UY - Uruguay 3
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
NI - Nicaragua 1
PA - Panama 1
QA - Qatar 1
SN - Senegal 1
ST - Sao Tome e Principe 1
SY - Repubblica araba siriana 1
TO - Tonga 1
TT - Trinidad e Tobago 1
TV - Tuvalu 1
Totale 6.543
Città #
Singapore 516
Hong Kong 292
Ashburn 276
Moscow 259
San Jose 244
Dallas 164
Beijing 148
Shanghai 141
Milan 136
Hefei 105
Lauterbourg 81
New York 79
Los Angeles 50
Ho Chi Minh City 48
Rome 47
Hanoi 39
Council Bluffs 36
Seattle 31
São Paulo 29
Boardman 28
Helsinki 26
Nuremberg 23
Amsterdam 20
Chennai 20
Denver 19
London 19
Orem 19
Montreal 18
Santa Clara 17
Turku 17
Warsaw 17
Washington 17
Mexico City 16
Munich 16
Brooklyn 15
Tokyo 15
Brescia 14
Canberra 14
Johannesburg 14
Poplar 13
Cesano Boscone 12
Florence 12
Rio de Janeiro 12
Atlanta 11
Houston 11
Manchester 11
Naples 11
Shenzhen 11
Ankara 10
Bang Kruai 10
Lappeenranta 10
Phoenix 10
Belo Horizonte 8
Frankfurt am Main 8
Toronto 8
Bari 7
Bologna 7
Curitiba 7
Da Nang 7
Falkenstein 7
Guangzhou 7
Hangzhou 7
Rabat 7
Sydney 7
The Dalles 7
Vienna 7
Assago 6
Charlotte 6
Chicago 6
City of London 6
Haiphong 6
Lahore 6
Pisa 6
Querétaro 6
Riyadh 6
Stockholm 6
Turin 6
Vancouver 6
Catania 5
Macerata 5
Mumbai 5
Salvador 5
San Francisco 5
Secaucus 5
Suzhou 5
Tashkent 5
Aracaju 4
Biên Hòa 4
Boston 4
Brasília 4
Cape Town 4
Carapicuíba 4
Casablanca 4
Chongqing 4
Contagem 4
Córdoba 4
Fes 4
Giza 4
Guarulhos 4
Hải Dương 4
Totale 3.498
Nome #
Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis 183
[18F]FDG-PET/CT Texture Analysis in “Hot” Thyroid Nodules: Results of the validation Cohort 130
Deep learning in Nuclear Medicine—focus on CNN-based approaches for PET/CT and PET/MR: where do we stand? 121
[F-18]FDG PET/CT in non-union: improving the diagnostic performances by using both PET and CT criteria 113
Random forest analysis to predict Disease-Free Survival using FDG-PET and CT in Lung Cancer 112
[18F]FDG PET/CT in Large Vessel Vasculitis: The Impact of Expertise and Confounders on Image Analysis 112
Allogeneic Stem Cell Transplantation (Allo-SCT) after Treatment with Programmed Cell Death-1 (PD-1) Checkpoint Inhibitors for Relapsed/Refractory Classic Hodgkin Lymphoma (R/R cHL) Is Associated with an Unprecedented Low Relapse Rate 110
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma 109
[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer 103
Challenging the significance of SUV-based parameters in a large-scale retrospective study on lung lesions 100
ALBI grade for outcome prediction in patients affected by hepatocellular carcinoma treated with transarterial radioembolization 100
A virtual biopsy of liver parenchyma to predict the outcome of liver resection 99
Match Point: Nuclear Medicine Imaging for Recurrent Thyroid Cancer in TENIS Syndrome—Systematic Review and Meta-Analysis 97
Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions 97
Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases 96
Climbing the steps of the evidence-based medicine pyramid: highlights from Annals of Nuclear Medicine 2019 95
Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma 95
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 92
Computed tomography (CT)-derived radiomic features differentiate prevascular mediastinum masses as thymic neoplasms versus lymphomas 91
Cardiac molecular pathways influenced by doxorubicin treatment in mice 91
Imaging-Based Prediction of Molecular Therapy Targets in NSCLC by Radiogenomics and AI Approaches: A Systematic Review 90
Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology 90
Cutting back on overdiagnosis – Occam’s Razor and unspecific bone uptakes in PSMA PET 89
Chemotherapy-Associated Liver Injuries: Unmet Needs and New Insights for Surgical Oncologists 88
Baseline FDG-PET/CT Radiomics to Predict Outcome in Lung Cancer Patients Treated with Surgery 85
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis 84
The five “W”s and “How” of Targeted Alpha Therapy: Why? Who? What? Where? When? and How? 83
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 81
Baseline Radiomic CT Features Differentiate Mediastinal Masses As Thymic Neoplasms Or Lymphomas 80
Towards clinical application of image mining: a systematic review on artificial intelligence and radiomics 75
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 74
Alternative Nuclear Imaging Tools for Infection Imaging 72
On the Automation of Radiomics-based Identification and Characterization of NSCLC 71
Convolutional Neural Networks Promising in Lung Cancer T-Parameter Assessment on Baseline FDG-PET/CT 70
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 70
Application of Convolutional Neural Networks is promising in the definition of T-stage in lung cancer 70
Radiomics of Liver Metastases: A Systematic Review 67
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical Study 67
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival 66
The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology 66
The Role of PET Imaging in the Differential Diagnosis between Radiation Necrosis and Recurrent Disease in Irradiated Adult-Type Diffuse Gliomas: A Systematic Review 65
What to Trust, PSA or [68Ga]Ga-PSMA-11: Learn from Experience 65
Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study 64
FAP expression in alpha cells of Langherhans insulae-implications for FAPI radiopharmaceuticals' use 64
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 64
Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer 63
Perceived risk and decision-making: navigating uncertainty in clinical practice 60
Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy 60
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model 60
Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the "flare phenomenon" to the "abscopal effect" 60
Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group 60
Hybrid PET/MRI in Infection and Inflammation: An Update About the Latest Available Literature Evidence 59
Methodological Aspects of Lymphoscintigraphy: Bicompartmental Versus Monocompartmental Radiocolloid Administration 59
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study 58
Explainable domain transfer of distant supervised cancer subtyping model via imaging-based rules extraction 58
Preoperative [11C]methionine PET to personalize treatment decisions in patients with lower-grade gliomas 56
Radiomics of Biliary Tumors: A Systematic Review of Current Evidence 55
PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome 55
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication 54
Value of FDG-PET/CT radiomic features in predicting response to anti-programmed death 1 (PD-1) antibodies treatment in refractory Hodgkin Lymphoma patients 54
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 54
Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges 53
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 53
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery 53
Methodological framework for radiomics applications in Hodgkin’s lymphoma 52
Recurrence-specific supervised graph clustering for subtyping Hodgkin Lymphoma radiomic phenotypes 52
Radioisotope-Guided Excision of Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma: Feasibility and Clinical Impact 52
The Development of an Intelligent Agent to Detect and Non-Invasively Characterize Lung Lesions on CT Scans: Ready for the "Real World"? 52
HCC Radioembolization with Yttrium-90 Polymer Beads (SIR-Spheres):Tc-99m-MAA SPECT/CT based dosimetry correlation with survival and tumor response 52
Quantitative imaging biomarkers in nuclear medicine: from SUV to image mining studies. Highlights from annals of nuclear medicine 2018 52
Radiomic Analysis of Intrahepatic Cholangiocarcinoma: Non-Invasive Prediction of Pathology Data: A Multicenter Study to Develop a Clinical-Radiomic Model 51
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 51
Patients' findings after COVID-19 infection and vaccinations: what to expect from [18F]FDG PET/CT 50
PET/CT radiomics in breast cancer: Mind the step 50
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 50
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 49
Radiomics-Based Inter-Lesion Relation Network to Describe [18F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer 48
Imaging-based representation and stratification of intra-tumor heterogeneity via tree-edit distance 48
Image Embeddings Extracted from CNNs Outperform Other Transfer Learning Approaches in Classification of Chest Radiographs 48
Interdisciplinarity: An essential requirement for translation of radiomics research into clinical practice -a systematic review focused on thoracic oncology 48
Present and future of target therapies and theranostics: refining traditions and exploring new frontiers-highlights from annals of Nuclear Medicine 2021 48
Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging 48
Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment 48
From pixels to predictions: the scrying power of molecular imaging 47
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary Cancers 47
Distributed learning: a reliable privacy-preserving strategy to change multicenter collaborations using AI 46
Mapping Tumor Heterogeneity via Local Entropy Assessment: Making Biomarkers Visible 45
COVID-19 vaccination, implications for PET/CT image interpretation and future perspectives 44
ED-B-Containing Isoform of Fibronectin in Tumor Microenvironment of Thymomas: A Target for a Theragnostic Approach 44
The prognostic power of [11C]methionine PET in IDH-wildtype diffuse gliomas with lower-grade histological features: venturing beyond WHO classification 44
Reply to: "Lack of evidence and criteria to evaluate artificial intelligence and radiomics tools to be implemented in clinical settings" 43
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure 43
Texture analysis and machine learning to characterize suspected thyroid nodules and differentiated thyroid cancer: Where do we stand? 42
Concerns About the Risk of Myeloid Malignancies After Radioiodine Therapy in Thyroid Cancer 42
FDG PET/CT as theranostic imaging in diagnosis of non-small cell lung cancer 42
Lymphoscintigraphy for the Differential Diagnosis of Peripheral Edema and Intracavitary Lymph Effusion 40
PSMA expression a promising biomarker to predictdifferentiated thyroid cancer aggressiveness and outcome 40
Dual adversarial deconfounding autoencoder for joint batch-effects removal from multi-center and multi-scanner radiomics data 39
The role of preoperative [11C]methionine PET in defining tumor-related epilepsy and predicting short-term postoperative seizure control in temporal lobe low-grade gliomas 35
The Predictive Role of Radiomics in Breast Cancer Patients Imaged by [18F]FDG PET: Preliminary Results from a Prospective Cohort 33
Totale 6.755
Categoria #
all - tutte 31.827
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.827


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023138 6 0 1 0 0 1 0 0 2 10 116 2
2023/2024717 8 145 82 45 56 69 33 85 41 35 31 87
2024/20251.548 157 53 21 59 80 143 177 158 305 194 114 87
2025/20264.447 382 352 198 620 449 168 620 322 1.122 214 0 0
Totale 6.851